JOINT FILING AGREEMENT
Exhibit
3
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
as
amended, each of the undersigned Reporting Persons hereby agrees to the joint
filing, along with all other such Reporting Persons, on behalf of each of them
of a statement on Schedule 13G (including amendments thereto) with respect
to
the Common Stock, $0.001 par value, of Replidyne, Inc., and that this Agreement
be included as an Exhibit to such joint filing. This Agreement may be executed
in any number of counterparts, all of which taken together shall constitute
one
and the same instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this Agreement as
of
this 14th day of February, 2007.
| By: |
X.
X.
Xxxx & Co., L.L.C., as
managing
member
|
|
| By: | /s/ Xxxx Xxxxxxx | |
|
Xxxx Xxxxxxx |
||
|
Managing
Director
|
||
|
X.
X. Xxxx & Co., L.L.C.
|
||
| |
|
|
| By: | /s/ Xxxx Xxxxxxx | |
|
Xxxx Xxxxxxx |
||
| Managing Director | ||
|
X.
X. Xxxx & Co., L.P.
|
||
| |
|
|
| By: | /s/ Xxxx Xxxxxxx | |
|
Xxxx Xxxxxxx |
||
| Managing Director | ||
|
Xxxxx
X. Xxxx
|
||
| |
|
|
| By: | /s/ Xxxx Xxxxxxx | |
|
Xxxx Xxxxxxx |
||
|
Attorney-in-Fact
for Xxxxx X. Xxxx
|
||
